Nanotechnology-based approaches hold substantial potential for improving the care of
patients with diabetes. Nanoparticles are being developed as imaging contrast agents to …

Traditional methods for diabetes management require constant and tedious glucose
monitoring (GM) and insulin injections, impacting quality of life. The global diabetic …

Purpose Glucagon-like peptide type 1 (GLP-1) is an incretin peptide that augments glucose-
stimulated insulin release following oral consumption of nutrients. Its message is transmitted …

The glucagonlike peptide 1 receptor (GLP-1R) is mainly expressed on β-cells in the islets of
Langerhans and is therefore an attractive target for imaging of the β-cell mass. In the present …

Purpose Glucagon-like peptide-1 receptor (GLP-1R) is a molecular target for imaging of
pancreatic beta cells. We compared the ability of [Nle 14, Lys 40 (Ahx-NODAGA-64 Cu) NH …

Since diabetes is becoming a global epidemic, there is a great need to develop early β-cell
specific diagnostic techniques for this disorder. There are two types of diabetes (ie, type 1 …

This review summarises recent research into combining the photosensitizing properties of
porphyrins with imaging techniques such as PET and NIR fluorescence for so called …

Medical imaging technologies are acquiring an increasing relevance to assist clinicians in
diagnosis and to guide management and therapeutic treatment of patients, thanks to their …

Context: Gastrointestinal peptide hormone receptors overexpressed in neuroendocrine
tumors (NET), such as somatostatin or glucagon-like peptide-1 (GLP-1) receptors, are used …

The clinical onset of type 1 diabetes is characterized by the destruction of the insulin-
producing β cells of the pancreas and is caused by autoantigen-induced inflammation …